Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Invivyd
Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination
May 29, 2026
Invivyd to Host First Quarter 2026 Financial Results and Corporate Update Call on May 14, 2026
May 28, 2026
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 28, 2026
Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit
May 25, 2026
Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles
May 24, 2026
Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health
May 24, 2026
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 24, 2026
Invivyd Announces Presentation at the World Vaccine Congress Washington
May 22, 2026
Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates
May 16, 2026
Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026
March 7, 2026
←
Previous Page
1
2
3
Next Page
→